Form 4 · EMR
Emerson Exec VP Michael J. Baughman reports an award of 42,015 shares
Part of a grouped insider digest: see all related filings with totals →
Michael J. Baughman, Emerson's Exec VP, CFO & CAO, filed a Form 4 on Nov 4, 2026 at 4:39 PM ET reporting transactions between Nov 2, 2026 and Nov 3, 2026.
The filing reports 42,015 shares in a grant or award (code A); and 18,819 shares withheld to pay the exercise price or tax (code F).
After these transactions, the filing lists 149,409 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Michael J. Baughman's directly held shares by 18.4%, from 126,213 to 149,409.
Reporting person
- Michael J. Baughman, Exec VP, CFO & CAO (as filed: Baughman Michael J)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | F | Common Stock | 4,406 | $167.95 | Disposed | 121,807 | Direct |
| 2026-11-02 | A | Common Stock | 28,177 | Acquired | 149,984 | Direct | |
| 2026-11-02 | F | Common Stock | 12,413 | $167.95 | Disposed | 137,571 | Direct |
| 2026-11-02 | A | Common Stock | 13,838 | Acquired | 151,409 | Direct | |
| 2026-11-03 | F | Common Stock | 2,000 | $166.43 | Disposed | 149,409 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 4, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Emerson company file → · More Emerson filings
Disclosures
- Editor holdings in EMR
- The editor holds no position in Emerson (EMR). As of Nov 11, 2026.
- Last updated
- Nov 4, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold EMR.